McCann Health & Great Guns Present 2nd Annual “Fighting For Your Creative Life” Seminar on Saturday, June 18 at 10:00 am June 16, 2016 – McCann Health and Great Guns are proud […]
SAN FRANCISCO, JUNE 13, 2016–Giant Creative/Strategy, LLC, the largest full-service independent healthcare communications agency on the West Coast, industry veteran Heidi Wright as Senior Vice President, Management Supervisor. Wright oversees […]
Klick Health execs say technology is key to strategic and creative brand building, keeping up with clients, remaining relevant – and in business TORONTO, ON/NEW YORK, NY – June 15, […]
The rapid study startup process can ensure studies are finely tuned for scientific validity.
The Greater Than One Group (GTO), the leading independent digital communications company, announced the addition of Kieran Walsh as Global Account Director.
Concerted effort by governments, regulators, and industry is rapidly expanding development of new therapies for the more than 7,000 known rare diseases.
Concentric Health Experience Names Three New SVP, Client Services Directors in Response to Record-Breaking 2016.
The outlook remains bright due to a favorable regulatory arena, support for biopharma-friendly legislation and development incentives, expanding scientific opportunities in key therapeutic areas such as immuno-oncology, and big pharma’s continued push to obtain innovation.
In mid-May, pharma giant Pfizer agreed to buy Anacor Pharmaceuticals for a total transaction value, net of cash, of $5.2 billion. Anacor is a biopharmaceutical company concentrated on discovering, developing and commercializing novel small-molecule therapeutics derived from its boron chemistry platform.
Researchers revealed the first U.S. case of a pathogen carrying a mutated strain of E. coli resistant to an antibiotic used as a final defense versus superbugs. As a result, there has been heightened concern that a post-antibiotic era will arrive earlier than predicted.